Fennec Pharmaceuticals (FENC) Assets Average (2011 - 2025)

Fennec Pharmaceuticals' Assets Average history runs 15 years deep, the most recent figure standing at $59.9 million for Q4 2025.

• Quarterly Assets Average rose 15.35% year-over-year to $59.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $59.9 million (up 15.35% YoY) and the FY2025 annual result came in at $57.7 million, up 60.84% from the prior year.
• Assets Average was $59.9 million for Q4 2025 at Fennec Pharmaceuticals, up from $47.1 million in the prior quarter.
• Across five years, Assets Average topped out at $66.2 million in Q2 2024 and bottomed at $17.4 million in Q2 2022.
• A 5-year average of $35.6 million and a median of $28.3 million in 2021 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average slumped 37.94% — and 2024, when it soared 220.8%.
• Fennec Pharmaceuticals' Assets Average stood at $24.2 million in 2021, then grew by 18.44% to $28.7 million in 2022, then retreated by 18.33% to $23.4 million in 2023, then surged by 121.74% to $51.9 million in 2024, then gained by 15.35% to $59.9 million in 2025.
• Business Quant data shows FENC's Assets Average at $59.9 million in Q4 2025, $47.1 million in Q3 2025, and $45.6 million in Q2 2025.